Tags Posts tagged with "marijuana"

marijuana

0 1298

Future Farm Closes on 15 Acres of Cannabis Zoned Land in Florida and Appoints John Sweeney as Chief Operating Officer

VANCOUVER, British Columbia, Feb. 8, 2017 /PRNewswire/ — Future Farm Technologies Inc. (the “Company” or “Future Farm”) (OTCQB: AGSTF) (CSE: FFT) is pleased to announce that it has closed on its previously announced definitive agreement to acquire a 15-acre parcel of land in Redland, Florida, in a county that is designated to legally cultivate, process and dispense cannabis. Redland is an unincorporated community within Miami-Dade County, with Biscayne National Park to the east and Everglades National Park to the west. Redland is primarily a Miami suburb and a major agricultural area. Miami-Dade County is referred to as the nation’s “Salad Bowl” and “Winter Bread Basket.”

“We are pleased to have reached this contract to acquire this prime parcel of land as it has a long history as a plant nursery, which was first established in 1963,” says Mr. William Gildea, Future Farm Technologies Inc.’s CEO and Chairman. Florida’s Legislature is beginning the process of figuring out how to implement Amendment 2, which allows for the expansion of legalized medical marijuana in Florida. The new law took effect on Tuesday, Jan. 3, 2017. The Florida Department of Health now has until June 3, 2017 to finalize its MMJ regulations and until September 3, 2017 to issue the first ID cards to patients. Amendment 2 was approved by 71 percent of Florida voters on Election Day, and will allow higher-strength marijuana to be used for a wider list of medical ailments.

With this acquisition, Future Farm has the potential, if fully licensed, to develop 15-acres of cannabis crops and is positioning itself to be a part of the Florida Cannabis market as it rolls out in 2017. If current state projections for the cannabis market size hold up to their $1.8B projection by 2020, Florida will have considerable demand for medical marijuana, even without factoring in the potential for recreational legislation.

This is an exciting acquisition for Future Farm as the 15-acre farm is located in a designated legal grow zone with close proximity to Miami. Future Farm is in a unique position as a Canadian based company because it is poised to quickly commence operations within the United States rather than potentially wait years to become a licensed producer under Canadian law.

Concurrent with this announcement, the Company is pleased to announce the appointment of John Sweeney as its Chief Operating Officer. Mr. Sweeney will transition into this executive position from his current role as a consultant and his big pharma background and expertise will help the Company capitalize on its current growth initiatives.

While serving as a consultant for the Company, Mr. Sweeney helped position the business firmly within the North American cannabis market through organic and inorganic growth initiatives. Going forward, Mr. Sweeney is going to play an important role in the next phase of the Company’s growth strategy.

Mr. Sweeney brings with him 16 years of direct cGMP (current Good Manufacturing Practices) manufacturing experience in operations of industry leading biotechnology companies including Pfizer, Wyeth, Genzyme and most recently as Vice President of Operations at Tilray, a 60,000-square foot federally licensed Canadian medical cannabis operation on Vancouver Island.

He has extensive knowledge and experience in the requirements of regulated manufacturing for commercial and clinical products and served as liaison for auditing regulatory agencies including the FDA and EMA. Mr. Sweeney holds an MS in Engineering Management from Tufts University in Medford, MA and a BS in Biology from the University of New Hampshire, Durham.

For further information, contact William Gildea, Director, at 617.834.9467.

On behalf of the Board,

Future Farm Technologies Inc.

William Gildea, CEO & Chairman

About Future Farm

The Company’s business model includes developing and acquiring technologies that will position it as a leader in the evolution of Controlled Environment Agriculture (CEA) for the global production of various types of plants. Future Farm provides scalable, indoor CEA systems that utilize minimal land, water and energy regardless of climate, location or time of year and are customized to grow an abundance of crops close to consumers, therefore minimizing food miles and its impact to the environment. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generate yields up to 10 times greater per square foot of land. The contained system provides many other benefits including seed to sale security, scalability, consistency due to year-round production, cost control, product safety and purity by eliminating environmental variability.

The Company is also in the business of designing and distributing LED lighting solutions utilizing the COB and MCOB technology. The Company is focused on delivering cost efficient lighting to North America via advanced e-commerce sites the Company owns and operates. LEDCanada.com which caters to B2B customers is a supplier of the newest and highest demand LED solutions. The Company also owns and operates COBGrowlights.com which caters to both large and small agriculture green houses and controlled cultivation centers.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

For further information, contact William Gildea, Director, at 617.834.9467.

0 1297

Less than a month ago, a Canadian-based innovative mobile health and telemedicine company announced that it developed a mobile application to support patients who have been prescribed medical cannabis.

The company, Reliq Health Technologies (RHT.V) (RQHTF), offers a hardware and software solution that allows patients to receive high-quality care at home.

Today, Reliq announced that it entered into a memorandum of understanding (MOU) with Invictus MD Strategies Corp. (IMH.CN: CSE) (IVITF: OTC) to develop a mobile application for cannabis patients and consumers and their clinical care teams.

Invictus MD is focused on acquiring licensed producers for cannabis cultivation in Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The company is focused on three verticals: 1) Cannabis cultivation in Canada, 2) Cannabis fertilizer and nutrients, and 3) Data and Delivery.

Invictus has been very successful with its strategy of acquiring and divesting cannabis businesses. In December, the company paid a $1 million dividend to its shareholders ($0.07 a share).

From the CEO

Invictus MD Chairman/CEO Dan Kriznic said, “Our wholly owned subsidiary: Poda Technologies Ltd. (Poda) is set for a launch in Q2 2017 of its Poda Pod vaporizer product which will provide an effective, reliable and convenient way to vaporize cannabis that is designed to appeal to modern retail and medical consumers.”

The Poda Pod vaporizer was designed to connect to users’ smartphones to provide real time information about dosage, to provide product characteristics, to track remaining contents, to find vendors nearby, and to customize their experience.

The chairman also said it is excited to see how Reliq’s product can support Invictus patients. Reliq’s platform will give Invictus the ability to collect relevant consumer data such as usage trends, frequency of usage and other relevant insights to improve the overall experience for medical marijuana patients.

A Deal Without Compromise

We are favorable on this announcement as we believe the companies will discover significant synergy opportunities between the two businesses.

Invictus owns 33.3% of AB Laboratories Inc., a licensed medical cannabis producer under the ACMPR (based out of Hamilton, Ontario). AB received its cultivation license in October 2016 and expects to receive its sales license in the second quarter of 2017.
The company also will own 100% of PlanC BioPharm Inc., a licensed producer applicant, once it raises $8 million for the acquisition of land and construction of a 30,000 sq. ft. cultivation facility. Invictus expects to receive a cultivation license in the fourth quarter of 2017.

We are favorable on the assets owned by Invictus as well as the opportunity for Reliq within these assets. This is a relationship to watch as we expect to see some exciting developments announced by these two companies.

2 2272

This morning Reliq Health Technologies (OTC:RQHTF) (TSX VENTURE:RHT) announced that through an MOU with Invictus MD Strategies Corp. (CSE:IMH)(OTC:IVITF) the company would be diving into the marijuana industry through the development of a mobile application for cannabis patients and consumers and their clinical care teams. Another clear example of how “Bio-tech” is beginning to carve its own space within the marijuana industry.

Reliq Health, a healthcare technology company focused on developing innovative mobile health and telemedicine solutions, has developed a novel SaaS (software as a service) solution for the community health care market. The solution provides automated remote patient monitoring in the home and secure cloud-based communication, care planning and collaboration for all members of the patient’s circle of care. Reliq’s secure platform allows clinicians to collect comprehensive data on patients’ clinical conditions, medication usage, symptoms, side effects and behaviours – creating a wealth of population health data.

“Studies consistently show that providing patients with the tools they need for self-management of their health conditions produces better health outcomes and reduces healthcare costs. Cannabis is prescribed to treat a wide range of conditions including arthritis, glaucoma, side effects from chemotherapy, chronic pain, multiple sclerosis and post-traumatic stress disorder.

Our cannabis app allows patients to track usage and record symptoms specific to their clinical condition, allowing patients and their care providers to determine optimum strain, dosing and mode of administration. Our platform will improve access to care by connecting patients with physicians in their community who have experience with medical marijuana, and supports physician-approved automated prescription refills through participating producers,” said Dr. Lisa Crossley, CEO of Reliq.

Invictus MD’s Chairman and CEO, Dan Kriznic, said, “Our wholly owned subsidiary: Poda Technologies Ltd. (“Poda“) is set for a launch in Q2 2017 of its Poda Pod vaporizer product which will provide an effective, reliable and convenient way to vaporize cannabis that is designed to appeal to modern retail and medical consumers.” The Poda Pod vaporizer product, made with medical-grade components, has been designed to connect to users’ smartphones via Bluetooth to provide real time information about dosage, product characteristics, track remaining contents, find vendors nearby, and customize their experience. Agreements are being negotiated to license the PODA products to the Access to Cannabis for Medical Purposes Regulations (“ACMPR“) and licensed producers in Canada, helping those producers better reach and serve consumers with convenient, refillable devices.

Mr. Kriznic added, “Invictus MD is excited and committed to working collaboratively with Reliq on this innovative mobile application to explore how Reliq’s solution can support Invictus’ commitment to its patients and consumers of cannabis products. Reliq’s technology platform will give Invictus the ability to collect relevant anonymized consumer data such as usage trends, frequency of usage and other relevant insights to improve the overall experience for medical marijuana patients.”

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the “Company”) does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.


Pursuant to an agreement between us and Reliq Health Technologies, Inc. we have been hired for a period of 30 days to publicly disseminate information about (RQHTF) including on the Website and other media including Facebook and Twitter. We are being paid $75,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (RQHTF), which we purchased in the open market. We plan to sell the “ZERO” shares of (RQHTF) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (RQHTF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

mCig Announces 5 Million Reduction in Shares Outstanding

mCig Inc. ( OTCQB : MCIG ), a diversified company servicing the legal cannabis, hemp, and CBD markets, announced today that it has begun the process of cancelling 5 million shares of its common stock.

“We are announcing to our shareholders that we have reduced our shares of common stock outstanding by 5 million shares,” stated Michael Hawkins, CFO of MCIG. “Building value for shareholders in a public company requires not only success in establishing a strong business and revenue model, but also maintaining the financial integrity that comes from prudently managing the stock capital structure of the company. During our review we were able to identify and negotiate terms of service that led to the cancellation of prior stock issuances.”


Click Here To View Full Article


 

$VPRB will be participating at TPE Tobacco Plus Expo in Las Vegas

VPR Brands, LP (OTC PINK: VPRB) is proud to announce its participation in the TPE Tobacco Plus Expo booth# 6053, in Las Vegas, Nevada on January 25-26th. Voters in Nevada just recently voted to legalize marijuana for recreational use and the TPE show is the 1st major industry trade show to take place there since.

Dan Hoff COO of VPR Brands says, “The Trade Shows and events are a fantastic way for us to gauge the response to our new 2017 product portfolio. Having personally attended the BIG Industry Show in Los Angeles just last week, I had the opportunity to speak with many customers, industry professionals, and even some of our shareholders about the industry and their thoughts. The overall response to our products was overwhelmingly positive and with Nevada passing for recreational cannabis use in this past election I Believe the Tobacco Plus expo Las Vegas will have a large turnout from the Cannabis sector. According to Arcview Market Research’s official market projection annual legal cannabis sales in Nevada are expected to increase from $121.6 million in 2016 to an estimated $630 million by 2020.″


Click Here To View Full Article


 

#ICYMI: Marijuana Stocks, Inauguration Day, & Trump’s Bump

Here we are, just after the official inauguration day of our 45th President of the United States of America, Donald Trump. A lot has been said about him over the last few years during the election race but what many may not have expected was a clear “Trump Bump” for marijuana stocks.

 


Click Here To View Full Article


 

Pursuant to an agreement between MAPH and VPRBrands, we were hired for a period of 30 days to publicly disseminate information about (VPRB) including on the Website and other media including Facebook and Twitter. We are being paid $15,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VPRB) which we purchased in the open market. . MAPH owns 2 million common restricted shares of mCig Inc. MAPH owns 10 million common restricted shares of Hemp Inc. We may buy or sell additional shares of any stocks mentioned, in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 2134

Marijuana Stocks, Inauguration Day, & Trump’s Bump

Here we are, just after the official inauguration day of our 45th President of the United States of America, Donald Trump. A lot has been said about him over the last few years during the election race but what many may not have expected was a clear “Trump Bump” for marijuana stocks.


Click Here To View Full Article


 

Facts Regarding Denver’s New Marijuana In Public Law

Denver has begun working on the country’s first law allowing use in public places like coffee shops and cannabis clubs. However, the details about what those marijuana clubs would look like are still unclear. Here are some answers to questions about the cannabis clubs headed to Denver.


Click Here To View Full Article


 

Veterans In Support Of Medical Marijuana



Indiana American Legion reached an agreement on Sunday that would support a medical cannabis study to treat injuries to military service members, such as traumatic brain injuries and PTSD. The veteran service organization said they are working to urge Indiana legislators to approve the private growth and research of medicinal cannabis and to reclassify marijuana as a drug with potential medical value.


Click Here To View Article


 

 

 PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

Medical Marijuana Shows Parkinson’s Patient Some Relief

Ian Frizell, age 55, was diagnosed with Parkinson’ disease in 2011. He has suffered from symptoms since 1995, which continually got worse over time. Ian has filmed a video to display what a significant difference a small amount of medical marijuana makes to his tremors. In the clip, he states that he recently underwent deep brain stimulation surgery, a medical implant that helps hide the effects of Parkinson’s. He switches the DBS device off to show the seriousness of his tremors.

 


Click Here To View Full Article


 

Research Reveals Some Of Marijuana’s Health Effects

 

It may essentially help some people sleep and ease chronic pain, but it is also possible to heighten the danger of triggering a heart attack or develop schizophrenia. A Federal advisory panel came to those those conclusions about cannabis in a recent report.

The analysts also called for a…


Click Here To View Full Article


 

Vitality Biopharma (VBIO)

 

Vitality Biopharma (VBIO) has been in our spotlight for the better part of the last few weeks and we’ve seen this cannabis biotech deliver real potential for gains. What started out as a $0.98 alert ended up turning into a $4.24 bull. Even after pulling into $1.93, VBIO managed several clear bounces. This will be something we’ll be continuing to monitor into the later half of the month as well. If you haven’t taken a look at this company yet, check out our full report via the link below.


Click Here To View Full VBIO Report


 

 

Pursuant to an agreement between MAPH and a non affiliate third party, we were hired for a period of 30 days to publicly disseminate information about (VBIO) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VBIO) which we purchased in the open market. We plan to sell “ZERO” shares of (VBIO) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (VBIO) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 1570

Vitality Biopharma (VBIO) To Present Today!

 

Today’s the day that Vitality Biopharma (VBIO) will be presenting at the Ninth Annual Biotech Showcase 2017 Conference. Company CEO Robert Brooke will provide a 30-minute overview of Vitality Biopharma’s business during his presentation and will be available to participate in one-on-one meetings with registered attendees.

This being one of the most active weeks in biotech has been highlighted by many large outlets as San Francisco has now become a city within a city for biotech investors and companies. We’ve seen VBIO have a much stronger week this week as compared to last and after closing last Thursday near its weekly lows, VBIO saw early signs of a rally on Friday (1-6).

This has continued into this week and the latest coverage that cannabis biotech could receive during this pivotal week could shed more light on companies like VBIO & their novel therapies. After seeing 2 week highs of $3.36 yesterday, we’ll be watching today to see what the reaction may be from the company’s presentation.

 


Click Here To View Full VBIO Report

 


 

 

$VPRB Announces The Launch Of Their Premier Product The Kush Army Knife

 

VPR Brands, LP and Kush Army Knives, LLC is proud to announce the launch of their premier product with its unique and proprietary multi-faceted product known as the Kush Army Knife, the ultimate cannabis multi-tool. This item is anticipated to be one of the top selling accessories within the cannabis sector in 2017. Developed in conjunction with VPR Brands who helped redesign, refine, and bring to market the final prototype the product will be making initial deliveries in late January.

The Kush Army Knife is…

 


Click Here To View Full Release


 

 

Restrictions With Legal Marijuana Threaten Industry’s Reform

 

Cannabis recently became legal for adults in the state of Nevada. However, farming it is illegal unless they live more than 25 miles away from a retail marijuana shop. This is an example of what’s called a “halo rule.” Marijuana Policy Project introduced this idea in the 2010 Proposition 203 that brought medical marijuana to Arizona.

It mandated that any patient living within 25 miles of a dispensary could not grow their own marijuana. They would have to register with and purchase their cannabis from their local authorized dispensary. At first, this meant that all patients could grow their own cannabis, as the law went into effect before any licenses had been awarded to dispensaries. However, as the dispensaries opened, every patient within that 1,964 square mile area had to remove their marijuana crops.

 


Click Here To View Full Article

 


 

 

Pursuant to an agreement between MAPH and a non affiliate third party, we were hired for a period of 30 days to publicly disseminate information about (VBIO) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VBIO) which we purchased in the open market. We plan to sell “ZERO” shares of (VBIO) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. Pursuant to an agreement between MAPH and VPRBrands, we were hired for a period of 30 days to publicly disseminate information about (VPRB) including on the Website and other media including Facebook and Twitter. We are being paid $15,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VPRB) which we purchased in the open market. We may buy or sell additional shares of (VPRB,VBIO) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

1 2536

Biotech Buzz Could Focus On Cannabis

San Francisco will be a hotbed for biotechnology this week. The annual JPMorgan Healthcare Conference kicks off on Monday the 9th and goes through Thursday the 12th. But this isn’t the only conference and there will surely be thousands of investors in the city to attend all kinds of presentations being made, which are focused on biotechnology & healthcare. Outside of just JPM’s conference, the crowd around Union Square also consists of the Biotech Showcase, which sets up at the Hilton San Francisco Union Square; and the OneMedForum across Post Street from the St. Francis.

Biotech_Showcase

There’s also the StartUp Health Festival on Montgomery Street and other conferences. Considering that thousands of people who aren’t going to invitation-only conferences like JPM, it would stand to reason that attention will be on the industry in full force this week.

Recently Vitality Biopharma (VBIO) announced that it would be presenting at the Biotech Showcase on Wednesday January 11th. The Showcase hosts over 2,800 attendees, over 5,600 one-on-one meetings, and will be expecting to see over 550 investors present.

Biotech Showcase™ is an investor and networking conference working to provide private and public biotech and life sciences companies with an opportunity to present to, and engage with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco during this week, which is widely viewed as setting the tone for the coming year…so JPMorgan is just the tip of the iceberg during San Fran’s biotech invasion.

“Biotech has historically outperformed the broader market during The J.P. Morgan Healthcare Conference,” biotech analysts at the firm wrote in a note to clients ahead of the event.

And we aren’t the only ones who could be seeing the potential “writing on the wall.” One of the presenters at the conference has even said, “…there’s a growing interest in medical cannabis among traditional health care institutions. This is a growing part of what is becoming mainstream health care.” As we said last week, even though we focus specifically on marijuana stocks, the biotech aspect of VBIO could be something to pay attention to heading into this week, considering the historic impact that the JPM conference (starts today) has had in the past for companies that have a stake in the space.

We said that this week could shed some light on many biotech companies including those involved with cannabis. Now we see that VBIO will be at ground zero, not just as another biotech company that could benefit from the shockwave but management will be in the exact location and presenting to the exact audiences.

Company CEO Robert Brooke will provide a 30-minute overview of Vitality Biopharma’s business during his presentation and will be available to participate in one-on-one meetings with registered attendees.

Event: Biotech Showcase Conference
Date: Wednesday, January 11, 2017
Time: 8:00 a.m. PT
Track: Room 8 (Ballroom Level)
Location: Hilton San Francisco Union Square, San Francisco, CA


 

 

Pursuant to an agreement between MAPH and a non affiliate third party, we were hired for a period of 30 days to publicly disseminate information about (VBIO) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VBIO) which we purchased in the open market. We plan to sell “ZERO” shares of (VBIO) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of ( VBIO) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 1226

Vitality Biopharma to Present at Biotech Showcase 2017

LOS ANGELES, CA–(Marketwired – Jan 9, 2017) – Vitality Biopharma, Inc. ( OTCQB : VBIO ) (“Vitality Biopharma,” “Vitality,” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced that it will present at the Ninth Annual Biotech Showcase 2017 Conference, on January 11, at the Hilton San Francisco Union Square.

Company CEO Robert Brooke will provide a 30-minute overview of Vitality Biopharma’s business during his presentation and will be available to participate in one-on-one meetings with registered attendees.

Event: Biotech Showcase Conference
Date: Wednesday, January 11, 2017
Time: 8:00 a.m. PT
Track: Room 8 (Ballroom Level)
Location: Hilton San Francisco Union Square, San Francisco, CA

Investors and other interested parties will be able to access a copy of the presentation by visiting the investors section of the Vitality Biopharma website at http://vitality.bio/investors/presentation.

About Biotech Showcase 2017
Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences.

About Vitality Biopharma ( OTCQB : VBIO )
Vitality Biopharma is dedicated to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. For more information, visit: www.vitality.bio. Follow us on Facebook, Twitter and LinkedIn.

Notice Regarding Forward-Looking Statements
This news release contains “forward-looking statements” as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

0 687

 Vitality Biopharma (VBIO) Set To Continue Trend Into “BigWeek” For Biotech?

 

Today’s the day that kicks off JPMorgan’s annual health-care conference; coined the industry’s biggest gathering. As we said last week, many in the space have said that this conference has proven to be a catalyst for the sector overall. So why mention this, as a marijuana focused outlet? Our most recent featured company Vitality Biopharma (VBIO) finds itself at the cross-roads where cannabis meets biotech. Not only did VBIO see a green close on Friday after 3 consecutive days of consolidation but it’s also heading into the week where biotech will seemingly be in the spotlight for many investors.

“Biotech has historically outperformed the broader market during The J.P. Morgan Healthcare Conference,” biotech analysts at the firm wrote in a note to clients ahead of the event.

And we aren’t the only ones who could be seeing the potential “writing on the wall.” One of the presenters at the conference has even said, “…there’s a growing interest in medical cannabis among traditional health care institutions. This is a growing part of what is becoming mainstream health care.” As we said last week, even though we focus specifically on marijuana stocks, the biotech aspect of VBIO could be something to pay attention to heading into this week, considering the historic impact that the JPM conference (starts today) has had in the past for companies that have a stake in the space.


Click Here To View Full VBIO Report


 

Dive Into The Steady Growing Cannabis Market

 

Co-founder of Vapium, a Canadian marijuana vape-maker states, “If you have a passion, any passion, we need advocates and allies. If you’re a baker, we need bakers. If you’re a lawyer, we need lawyers. Anyone who has empathy for people who need weed, and is driven, is welcome in the marijuana industry. There’s still so much opportunity.” The cannabis industry seems like it’s ready to take off. In 2016, the legal weed market in North America Generated $6.7 billion, up 30% from 2015, Arcview Market Research announced.

Washington DC has passed laws allowing…


Click Here To View Full Article


 

Lets Take a Deeper Look at California’s Most Popular Crop

 

California was already known as a major cannabis producer well before it legalized recreational marijuana in November. The state’s marijuana crop is not only the most profitable product in the nation’s biggest agricultural state, it is much farther ahead of the next most popular crop, according to the Orange County Register. California’s mild climate made Central Valley the breadbasket of the world at one time and provided the United States with fruits and vegetables that grew in very few other places. However, the biggest crop in California’s assorted bounty is currently marijuana.


Click Here To View Full Article


Pursuant to an agreement between MAPH and a non affiliate third party, we were hired for a period of 30 days to publicly disseminate information about (VBIO) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VBIO) which we purchased in the open market. We plan to sell “ZERO” shares of (VBIO) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of ( VBIO) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements